Intuitive Surgical reports Q3 results, takes $450M antitrust charge and narrows da Vinci growth outlook
Intuitive Surgical posted third‑quarter revenue of $3.05 billion and adjusted earnings per share of $3.00, beating estimates. The company recorded a $450 million antitrust settlement charge that cut GAAP net income to $523 million ($1.49 per share). U.S. da Vinci procedure growth slowed to 10%, the lowest since the COVID pandemic, prompting a narrowed 2026 procedure‑growth outlook of 14‑15%. Management said it will cut instrument and accessory revenue per procedure by 3‑5% to stimulate volume.
Why it matters
The settlement charge reduces GAAP earnings and may pressure the stock price, as reflected by a 6‑8% pre‑market decline. The lower U.S. growth outlook and planned price cuts could temper future revenue growth expectations, according to the company’s guidance.
Key facts
- 1Q3 revenue was $3.05 billion, up 22% year over year. finance.yahoo.com
- 2Adjusted EPS for the quarter was $3.00, beating the $2.64 consensus. finance.yahoo.com
- 3The company recorded a $450 million antitrust settlement charge. tokenpost.com
- 4U.S. da Vinci procedure growth was 10% in the quarter, the lowest since COVID. finance.yahoo.com
- 5Intuitive narrowed its 2026 da Vinci procedure growth outlook to 14‑15%, from a prior range of 13.5‑15.5%. finance.yahoo.com
- 6Management plans to cut instrument and accessory revenue per procedure by 3‑5% to boost volume. finance.yahoo.com
Summary written by AlphAI AI Desk from 2 of 2 sources. Not investment advice. Figures are as stated by the linked sources.